Variant report

Variant	rs73338525
Chromosome Location	chr12:57513010-57513011
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr12:57508450..57511232-chr12:57511653..57513684,3	K562	blood:
2	chr12:57502941..57507087-chr12:57511781..57514626,3	K562	blood:
3	chr12:57503627..57505712-chr12:57512717..57514306,2	K562	blood:
4	chr12:57398143..57400588-chr12:57512007..57514365,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000166860	Chromatin interaction
ENSG00000166888	Chromatin interaction

Extended variants
information (count: 7 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:4)

rs_ID	r²[population]
rs34890469	0.91[AFR][1000 genomes]
rs59902070	0.91[AFR][1000 genomes]
rs61626321	0.91[AFR][1000 genomes]
rs73340505	1.00[AFR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1040850	chr12:57055011-57679209	Strong transcription Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
2	nsv428590	chr12:57329214-57527358	Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Weak transcription ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
3	nsv832428	chr12:57340609-57535694	Strong transcription Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	103 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:52 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:57505800-57521800	Weak transcription	Spleen	Spleen
2	chr12:57506200-57520000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
3	chr12:57506200-57520400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr12:57506600-57520400	Weak transcription	Stomach Mucosa	stomach
5	chr12:57506600-57520600	Weak transcription	H1 Cell Line	embryonic stem cell
6	chr12:57506600-57520600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
7	chr12:57506800-57518200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
8	chr12:57506800-57519200	Weak transcription	Liver	Liver
9	chr12:57511200-57513400	Weak transcription	K562	blood
10	chr12:57511800-57513600	Enhancers	Primary monocytes fromperipheralblood	blood
11	chr12:57511800-57513600	Enhancers	HMEC	breast
12	chr12:57511800-57513800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr12:57511800-57513800	Enhancers	Monocytes-CD14+_RO01746	blood
14	chr12:57511800-57513800	Enhancers	NHEK	skin
15	chr12:57512000-57513600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr12:57512000-57513600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr12:57512000-57513800	Enhancers	Primary B cells from cord blood	blood
18	chr12:57512200-57513400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
19	chr12:57512200-57513400	Enhancers	Primary B cells from peripheral blood	blood
20	chr12:57512200-57513400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
21	chr12:57512200-57513800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr12:57512200-57513800	Enhancers	Muscle Satellite Cultured Cells	--
23	chr12:57512200-57513800	Enhancers	Hela-S3	cervix
24	chr12:57512200-57513800	Enhancers	HSMM	muscle
25	chr12:57512200-57513800	Enhancers	NHDF-Ad	bronchial
26	chr12:57512200-57513800	Enhancers	Osteobl	bone
27	chr12:57512400-57513200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
28	chr12:57512400-57513200	Enhancers	Duodenum Mucosa	Duodenum
29	chr12:57512400-57513200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
30	chr12:57512400-57513200	Enhancers	Left Ventricle	heart
31	chr12:57512400-57513400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
32	chr12:57512400-57513400	Enhancers	Adipose Nuclei	Adipose
33	chr12:57512400-57513600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr12:57512400-57513600	Enhancers	NHLF	lung
35	chr12:57512400-57513800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr12:57512600-57513200	Enhancers	Primary hematopoietic stem cells short term culture	blood
37	chr12:57512600-57513200	Enhancers	Colonic Mucosa	Colon
38	chr12:57512600-57513200	Enhancers	Fetal Lung	lung
39	chr12:57512600-57513200	Enhancers	Right Atrium	heart
40	chr12:57512600-57513200	Enhancers	NH-A	brain
41	chr12:57512600-57513400	Enhancers	HSMMtube	muscle
42	chr12:57512600-57513600	Enhancers	Primary hematopoietic stem cells	blood
43	chr12:57512600-57513600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr12:57512600-57513600	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
45	chr12:57512600-57513800	Enhancers	A549	lung
46	chr12:57512800-57513200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
47	chr12:57512800-57520200	Weak transcription	Rectal Mucosa Donor 31	rectum
48	chr12:57512800-57520400	Weak transcription	Skeletal Muscle Female	skeletal muscle
49	chr12:57513000-57513400	Flanking Active TSS	GM12878-XiMat	blood
50	chr12:57513000-57513600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links